South Korea · Delayed Price · Currency is KRW Sam-A Pharm. Statistics
Total Valuation
Sam-A Pharm. has a market cap or net worth of KRW 85.14 billion. The enterprise value is -6.18 billion.
| Market Cap | 85.14B |
| Enterprise Value | -6.18B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Sam-A Pharm. has 6.10 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 6.10M |
| Shares Outstanding | 6.10M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 68.45% |
| Owned by Institutions (%) | n/a |
| Float | 1.93M |
Valuation Ratios
The trailing PE ratio is 8.08.
| PE Ratio | 8.08 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | 6.97 |
| P/OCF Ratio | 5.96 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.11, with a Debt / Equity ratio of 0.03.
| Current Ratio | 10.11 |
| Quick Ratio | 8.96 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 0.53 |
| Interest Coverage | 12.43 |
Financial Efficiency
Return on equity (ROE) is 4.65% and return on invested capital (ROIC) is 4.10%.
| Return on Equity (ROE) | 4.65% |
| Return on Assets (ROA) | 1.37% |
| Return on Invested Capital (ROIC) | 4.10% |
| Return on Capital Employed (ROCE) | 2.32% |
| Weighted Average Cost of Capital (WACC) | 5.29% |
| Revenue Per Employee | 230.94M |
| Profits Per Employee | 33.69M |
| Employee Count | 305 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.96 |
Taxes
| Income Tax | -709.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.71% in the last 52 weeks. The beta is 0.19, so Sam-A Pharm.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | -18.71% |
| 50-Day Moving Average | 13,130.20 |
| 200-Day Moving Average | 14,948.60 |
| Relative Strength Index (RSI) | 60.91 |
| Average Volume (20 Days) | 2,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sam-A Pharm. had revenue of KRW 72.28 billion and earned 10.55 billion in profits. Earnings per share was 1,727.34.
| Revenue | 72.28B |
| Gross Profit | 40.28B |
| Operating Income | 5.48B |
| Pretax Income | 9.84B |
| Net Income | 10.55B |
| EBITDA | 10.40B |
| EBIT | 5.48B |
| Earnings Per Share (EPS) | 1,727.34 |
Balance Sheet
The company has 97.81 billion in cash and 6.49 billion in debt, with a net cash position of 91.32 billion or 14,961.85 per share.
| Cash & Cash Equivalents | 97.81B |
| Total Debt | 6.49B |
| Net Cash | 91.32B |
| Net Cash Per Share | 14,961.85 |
| Equity (Book Value) | 229.65B |
| Book Value Per Share | 37,626.49 |
| Working Capital | 119.37B |
Cash Flow
In the last 12 months, operating cash flow was 14.28 billion and capital expenditures -2.06 billion, giving a free cash flow of 12.22 billion.
| Operating Cash Flow | 14.28B |
| Capital Expenditures | -2.06B |
| Depreciation & Amortization | 4.92B |
| Net Borrowing | -3.66B |
| Free Cash Flow | 12.22B |
| FCF Per Share | 2,002.67 |
Margins
Gross margin is 55.73%, with operating and profit margins of 7.59% and 14.59%.
| Gross Margin | 55.73% |
| Operating Margin | 7.59% |
| Pretax Margin | 13.61% |
| Profit Margin | 14.59% |
| EBITDA Margin | 14.39% |
| EBIT Margin | 7.59% |
| FCF Margin | 16.91% |
Dividends & Yields
This stock pays an annual dividend of 850.00, which amounts to a dividend yield of 6.09%.
| Dividend Per Share | 850.00 |
| Dividend Yield | 6.09% |
| Dividend Growth (YoY) | 6.25% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 49.20% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 6.04% |
| Earnings Yield | 12.39% |
| FCF Yield | 14.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 29, 2008. It was a forward split with a ratio of 1.02005.
| Last Split Date | Dec 29, 2008 |
| Split Type | Forward |
| Split Ratio | 1.02005 |
Scores
Sam-A Pharm. has an Altman Z-Score of 5.05 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.05 |
| Piotroski F-Score | 5 |